institutional | VYDENCE®

#1 in the world’s second largest aesthetic market with the most versatile portfolio of medical devices.

VYDENCE® was born in 2016 as a result of the merger between INDUSTRA Technologies and ADVANCE Medical, consolidating itself in Brazil as the largest company of aesthetic medical equipment.
Its DNA is genuinely Brazilian, but with the American way of making things happen.

VYDENCE comes from the Portuguese word “vidência” which means the power or gift of “predicting the future.”
Development, manufacturing and distribution of medical devices for aesthetic markets in dermatology, plastic surgery, phlebology and other specialties.

INSTITUTIONAL INVESTORS

BOARD OF DIRECTORS

Fred Aslan

Executive Chairman,
VYDENCE® Medical

André Tanaka

CEO,
VYDENCE® Medical

Bryan Roberts

General Partner,
VENROCK

Darren Hite

Partner,
Aberdare Ventures

Paul McCreadie

Partner,
Arboretum Ventures

The reason we chose VYDENCE®

“With the expertise of a North American group of venture capital funds in the area of technology, we research emerging markets to identify companies and products that lead in these markets, but whose technology is world-class.
We chose to invest in VYDENCE because they dominate the Brazilian market – the second largest aesthetic market in the world. VYDENCE had over 7,500 systems installed and their system is the most versatile in the world, a key feature for emerging markets, and now these systems are going global with very compelling advantages over other available products.”

Fred Aslan, MD

Executive Chairman VYDENCE® Medical

VYDENCE®: A GROWING COMPANY

The only company developing and manufacturing solid-state LASERs in Latin America, with the exclusive handPICO® technology.

We were the 1st company in Latin America to develop and manufacture a LASER platform that has important certifications such as FDA, Health Canada and CE.

We have almost 300 employees with qualification and training to offer the market the best in LASER technologies.

#1 Market Share
Absolute leader in the world’s 2nd largest aesthetic market, and almost 3,000 platforms sold worldwide.

Brazilian DNA
We are a genuinely Brazilian company focused on competitiveness and international growth, including the United States.

MISSION

To offer maximum safety and performance with technology and service excellence, contributing to medical practice effectiveness and patient well-being.